BPC-157 10 mg Vial Research Peptide BPC-157 (Body Protection Compound-157) is een synthetisch pentadecapeptide dat is afgeleid van een eiwitfragment uit humaan maagsap

Philip Kistler Stroke Research Center, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, USA, Boston, United States, 2 Center for Imaging Sciences and Medical Physics, Department of Medical Imaging, Hematology, and Clinical Oncology, Ribeirao Preto Medical School, University of So Paulo, So Paulo, Brazil, 3 Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL, USA, Chicago, United States, 4 Department of Biomedical Engineering, Illinois Institute of Technology, Chicago, IL, USA, Chicago, United States, 5 MassGeneral Institute for Neurodegenerative Disease, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA, USA, Charlestown, United States Background and Aims: Cerebral Amyloid Angiopathy (CAA), characterized by amyloid- accumulation in leptomeningeal and cortical vessels, is a leading cause of intracerebral hemorrhage (ICH) lacking effective treatment options
Br J Nutr 1989
Weekly Schedule Options Standard Protocol (5 days on, 2 days off): This is the most common schedule